Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Cancer Research Institute
Dec 30, 2023, 17:29 |
Blog
Paolo Tarantino: Ikigai
Paolo Tarantino, Medical Oncologist and Research Fellow at the Dana-Farber Cancer Institute, shared a post…
Dec 29, 2023, 15:35 |
Blog
Vivek Subbiah: Tumor-agnostic therapies advance possibilities for Precision Medicine
Vivek Subbiah shared on LinkedIn: ''Tumor-agnostic therapies advance possibilities for Precision Medicine. Genomics are driving…
Dec 29, 2023, 05:08 |
Blog
Vivek Subbiah: 1 in 3 academic physicians report they are considering leaving their institution within 2 years
Vivek Subbiah shared a post on X/Twitter: ''1 in 3 academic physicians report they are…
Dec 29, 2023, 04:56 |
Blog
Rosandra Kaplan: T cell and myeloid populations that contribute to GD2 CART expansion
Rosandra Kaplan, Senior Investigator Physician Scientist Pediatric Oncologist at National Cancer Institute (NCI), on LinkedIn:…
Dec 27, 2023, 17:02 |
Blog
Vivek Subbiah: Forward-thinking journal on AI in Oncology and precision medicine
Vivek Subbiah shared on X/Twitter: Just in time for the holidays. Nice to get the…
Dec 27, 2023, 14:02 |
Drugs
Vivek Subbiah: The FDA just finalized the draft guidance for 'RARE DISEASE DRUG DEVELOPMENT'
Vivek Subbiah recently shared on LinkedIn: "Wow! The FDA just finalized the draft guidance for…
Dec 27, 2023, 08:59 |
Insight
Jonas Nilsson: Interesting and balanced discussion on a recent safety signal of CAR-T cells in plasma cell disorders
Jonas Nilsson Chair of Melanoma Discovery at The University of Western Australia and Harry Perkins…
Dec 26, 2023, 04:08 |
Dialogues
OncoDaily Dialogues #4 - Therese Mulvey / Hosted by Roupen Odabashian
In our series "OncoDaily Dialogues," we continue to spotlight eminent figures in oncology, sharing their…
Dec 25, 2023, 16:45 |
Insight
Vivek Subbiah: Pleased to share the work of our amazing RET precision medicine team as we review
Vivek Subbiah shared on LinkedIn: "Hot off the press! Pleased to share the work of…
Dec 24, 2023, 18:54 |
Drugs
Laurie Glimcher: Belzutifan is approved by the FDA
Laurie Glimcher, President and CEO of Dana-Farber Cancer Institute, shared on X/Twitter: "Exciting news that…
301
302
303
304
305
All:
3235
Posts:
3021 - 3030
Inside OncoDaily Party Barcelona
Zainab Shinkafi-Bagudu has been elected as UICC President-Elect 2024-2026
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Victor Ambros and Gary Ruvkun Awarded 2024 Nobel Prize in Medicine for MicroRNA Discovery
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube